IDENTITY
CompoundTesamorelin
BrandDragon Pharma
Strength5 mg
FormLyophilized Vial
ClassGrowth Hormone Releasing Peptide
PEPTIDE PROFILE
TypeGHRH Analog
TargetGrowth Hormone Pathway
AdministrationSubcutaneous (SC)
Half-lifeApprox. 30 minutes
StorageRefrigerated
PHARMACOLOGY
MechanismStimulates GH Release
IGF-1Increased Production
PathwayGHRH Receptor
CategoryPeptide Hormone
Clinical UseHIV-Associated Lipodystrophy
STORAGE & PACKAGE
PackageMulti-dose Vial
Before Mixing2–8°C
After MixingRefrigerated
ProtectionLight Protection
FormFreeze-dried Powder
CLINICAL DOSING PROFILE
Standard Dose2 mg/day SC
AdministrationOnce Daily
Injection TimeUsually Before Bed
DurationClinical Programs Up To 26 Weeks
UsageMedical Supervision
USAGE PROFILE
Week 1-4GH / IGF-1 Response
Week 5-12Metabolic Effects
Week 12+Continued Clinical Evaluation
GoalBody Composition Support
StabilityDaily Administration
ADMINISTRATION
RouteSubcutaneous Injection
SiteAbdominal Area
FrequencyDaily
PreparationReconstitution Required
TimingConsistent Daily Schedule
COMPATIBILITY
RecoverySleep & Nutrition Support
TrainingResistance Exercise
MonitoringIGF-1 Levels
HealthMetabolic Monitoring
SupportMedical Follow-up
MECHANISM OF ACTION
ReceptorGHRH Receptor
HormoneGrowth Hormone
EffectGH Secretion Increase
IGF-1Liver Production
ProcessEndocrine Signaling
PHARMACOKINETICS
AbsorptionRapid SC Absorption
PeakShort Plasma Exposure
MetabolismPeptide Degradation
ActionGH Pulse Stimulation
ClearanceProteolytic Pathways
SAFETY PROFILE
Common EffectsInjection Site Reactions
GlucoseMonitor Levels
IGF-1Monitor Response
FluidPossible Retention
Medical UsePrescription Based
CHEMICAL PROFILE
FormulaC152H252N44O42
ClassSynthetic Peptide
StructureGHRH Analog
Molecular WeightApprox. 3367 Da
CAS218949-48-5
OVERVIEW
Tesamorelin is a synthetic growth hormone releasing hormone analog designed to stimulate endogenous growth hormone secretion. It is primarily studied in clinical settings for effects on body composition, visceral adipose tissue reduction and IGF-1 regulation.
BENEFITS
- Stimulates natural GH release
- Supports IGF-1 production
- May improve body composition markers
- Supports recovery physiology
- Peptide-based mechanism
POTENTIAL RISKS
- Injection site irritation
- Fluid retention
- Glucose metabolism changes
- Joint discomfort
- IGF-1 elevation
CONCLUSION
Dragon Pharma Tesamorelin 5 mg is a peptide formulation containing tesamorelin, a GHRH analog that activates growth hormone signaling pathways. Its pharmacological profile is based on stimulation of endogenous GH release and subsequent IGF-1 activity.
The compound requires careful handling, appropriate storage, and monitoring of relevant biomarkers during clinical use. Individual response depends on health status, endocrine function and medical supervision.
REFERENCES
Tesamorelin Clinical Information: PubMed
FDA Medication Information: FDA
NCBI Biomedical Database: NCBI
December 1, 2025
Tesamorelin is legit! Dosing 2mg every night, I’ve seen great results in six weeks—less belly fat and better tone. Quality is excellent. The shop handled my order professionally, secure checkout, responsive support, and fast international delivery (10 days). Discreet packaging and fair pricing. Highly reliable vendor.